Deep Health AI India Limited Board Approves Rights Issue of Up to Rs. 25.00 Crores

The Board of Directors of Deep Health AI India Limited , formerly known as Deep Diamond India Limited, convened a meeting on May 04, 2026, at its registered office located at 506-509, Fifth Floor, Apeksha, Plot No. 256, Sector 11, Udaipur, Rajasthan. The meeting commenced at 02:30 P.M. and concluded at 04:00 P.M. During the meeting, the board considered and approved a proposal to raise funds through a rights issue of fully paid-up equity shares to eligible existing shareholders.

Rights Issue Approval

The board approved raising funds through the issue of fully paid-up equity shares on a rights basis to the existing equity shareholders of the company, for an amount aggregating up to Rs. 25.00 crores (Rupees Twenty-Five Crores). The issue is subject to receipt of statutory and regulatory approvals in accordance with the provisions of the Companies Act, 2013, the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, and other applicable laws. The record date for determining eligible shareholders is yet to be determined and will be notified subsequently.

The key details of the proposed rights issue, as disclosed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, are as follows:

Parameter: Details Type of Securities: Fully paid-up Equity Shares of face value of Re. 1 each Type of Issuance: Rights issue to existing shareholders Total Amount: Up to Rs. 25.00 Crores (Rupees Twenty-Five Crores) Cancellation/Termination: N.A.

Rights Issue Committee Constituted

To give effect to the rights issue, the board constituted a Rights Issue Committee and authorised its members to decide on the terms and conditions of the issue. The committee's mandate includes, but is not limited to, the following:

Determining the final issue size and amount

Fixing the rights entitlement ratio and issue price

Setting the record date and schedule of the rights issue

Approving the letter of offer

Appointment of intermediaries and legal counsel, if required

Allotment of shares and other related matters

Draft Letter of Offer and Regulatory Filing

The board also approved the Draft Letter of Offer for fund raising by way of the rights issue and authorised the company to apply for in-principal approval for the rights issue of up to Rs. 25.00 crores under Regulation 28(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The outcome of the board meeting was communicated to BSE Limited under Regulation 30 of the SEBI Listing Regulations. The disclosure was signed by Narayan Singh Rathore, Managing Director of the company.

Deep Health AI India Limited (formerly known as Deep Diamond India Limited) has successfully completed the relocation of its registered office from Maharashtra to Rajasthan, marking a significant administrative milestone for the pharmaceutical and healthcare company.

Regulatory Compliance and Notification

The company formally notified BSE Limited on April 14, 2026, regarding the completion of its registered office relocation in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Managing Director Narayan Singh Rathore signed the official communication, confirming all regulatory requirements had been fulfilled.

Office Relocation Details

The registered office has been shifted from its previous location at "309, 3rd Floor, V Star Plaza Plot No. 16 Chandavarkar Road, Opp. Saraswat Bank, Opposite Raj Mahal Hotel, Borivali West, Maharashtra, India, 400092" to the new address at "506-509, 5th Floor, Apeksha, Plot No. 256, Main Road, Hiran Magri, Sector 11, Udaipur, Rajasthan-313001."

Parameter: Details Previous Location: Borivali West, Maharashtra New Location: Udaipur, Rajasthan Previous ROC: Mumbai New ROC: Jaipur Approval Date: March 26, 2026 Regional Director Order: February 09, 2026

Regulatory Approvals and Documentation

The Ministry of Corporate Affairs issued the Certificate of Registration of Regional Director's Order for change of State on March 26, 2026. This certificate was signed by Atma Sah, serving as Assistant Registrar of Companies/Deputy Registrar of Companies/Registrar of Companies at ROC Jaipur. The interstate relocation required approval from the Regional Director (Western Region), which was granted through an order dated February 09, 2026.

Corporate Identity Updates

Following the successful relocation, the company's Corporate Identity Number (CIN) has been updated to L24100RJ1994PLC112895, reflecting the change in state jurisdiction from Maharashtra (MH) to Rajasthan (RJ). The company continues to operate under its current name, Deep Health AI India Limited, having previously been known as Deep Diamond India Limited.

Shareholder Approval Process

The registered office relocation was initially approved through a special resolution passed by shareholders in the Annual General Meeting held on September 27, 2024. The Memorandum of Association was subsequently amended to reflect the change in registered office clause, with the Regional Director's confirmation received on February 09, 2026.

Business Operations and Focus

According to the company's Memorandum of Association, Deep Health AI India Limited operates in the pharmaceutical and healthcare sector, focusing on manufacturing, marketing, and distribution of drugs, pharmaceuticals, and medical products. The company's business activities include research and development in biotechnology, biochemical processes, and various pharmaceutical formulations including tablets, capsules, and medical equipment.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.